PKC Inhibitor Set

Primary Target
PKC

Secondary Target
PKCα, PKCβ

Toxicity: Multiple Toxicity Values, refer to MSDS (O)

Contains 250 µg of Bisindolylmaleimide I (Cat. No. 203290), 50 µg of Calphostin C, Cladosporium cladosporioides (Cat. No. 208725), 5 mg of Chelerythrine Chloride (Cat. No. 220285), 500 µg of Gö 6976 (Cat. No. 365250), 500 µg of Myristoylated Protein Kinase C Inhibitor 20-28, Cell-Permeable (Cat. No. 476480), and 1 mg of Ro-32-0432 (Cat. No. 557525). Supplied with a data sheet.

Inhibition of protein kinase C (PKC) is one of the most direct methods for investigating its role in cellular metabolism and tumorigenesis. Calbiochem^® brand is pleased to offer a convenient set of PKC inhibitors for your research needs. Supplied with a data sheet.

The PKC Inhibitor Set controls the biological activity of PKC. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

Eicholtz, T., et al. 1993. J. Biol. Chem.268, 1982.
Kleinschroth, J., et al. 1993. Bioorg. Med. Chem. Lett.3, 1959.
Martiny-Baron, G.M., et al. 1993. J. Biol. Chem.268, 9194.
Ward, N.E., and O′Brian, C.A. 1993. Biochemistry32, 11903.
Wilkinson, S.E., et al. 1993. Biochem. J.294, 335.
Barg, J., et al. 1992. J. Neurochem.59, 1145.
Gopalakrishna, R., et al. 1992. FEBS Lett.314, 149.
Bruns, R.F., et al. 1991. Biochem. Biophys. Res. Commun.176, 288.
Toullec, D., et al. 1991. J. Biol. Chem.266, 15771.
Herbert, J.M., et al. 1990. Biochem. Biophys. Res. Commun.1172, 993.
Tamaoki, T., et al. 1990. Biotechnology8, 732.
Kobayashi, E., et al. 1989. Biochem. Biophys. Res. Commun.159, 548.

Following reconstitution, aliquot and freeze -20°C.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany